Monitor the reconvened meeting on August 17, 2026, for vote results. If the charter amendment passes, it could lower barriers for activist or takeover activity, potentially increasing stock volatility. If it fails, management may face continued governance pressure.
Price Chart
Executive Summary
Tempest Therapeutics adjourned its special meeting of stockholders on July 27, 2026, due to insufficient votes to approve a charter amendment replacing supermajority voting requirements with written consent provisions. The meeting will reconvene on August 17, 2026, as management seeks additional votes to reach the 75% threshold required for passage. The adjournment signals a governance bottleneck and potential activist pressure, with the outcome of the vote still uncertain.
Key Financial Metrics
Key Facts
- Special meeting adjourned on July 27, 2026, due to insufficient votes for a charter amendment to replace supermajority voting requirements and permit stockholder action by written consent.
- 10,031,446 shares (67.7% of 14,806,997 outstanding) were present, constituting a quorum, but the proposal requires 75% affirmative vote of all votes entitled to be cast.
- Meeting reconvenes on August 17, 2026; record date remains May 28, 2026; previously submitted proxies remain valid unless revoked.
- Company engaged Sodali & Co. to assist with solicitation to achieve quorum and adequate votes.
Financial Impact
No direct financial impact disclosed; governance change could reduce future takeover defenses and enable shareholder action by written consent.
Risk Factors
- Proposal may fail again if management cannot secure the required 75% supermajority, leaving governance structure unchanged.
- Adjournment and low turnout may signal shareholder dissatisfaction or lack of engagement, increasing risk of activist intervention.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-321197 |
| Document: 0001193125-26-321197-index-headers.html | 0001193125-26-321197 |
| Document: 0001193125-26-321197-index.html | 0001193125-26-321197 |
| Document: 0001193125-26-321197.txt | 0001193125-26-321197 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | DEF 14A | $0.5102 | awaiting T+20 | awaiting T+20 | $0.5110 (−0.16%) |
Oct 20, 2026 7d ago | DEFA14A | $0.5282 | awaiting T+20 | awaiting T+20 | $0.5110 (−3.26%) |
Oct 20, 2026 7d ago | 8-K | $0.5282 | awaiting T+20 | awaiting T+20 | $0.5110 (−3.26%) |
Oct 19, 2026 8d ago | 8-K | $0.5762 | awaiting T+20 | awaiting T+20 | $0.5110 (−11.32%) |
Oct 2, 2026 26d ago | EFFECT | $0.8112 | awaiting T+20 | awaiting T+20 | $0.5110 (+37.01%) |
Sep 25, 2026 4w ago | S-3 | $0.8316 $0.5102 | ▲ +38.65% | ▲ +38.62% | $0.5110 (+38.55%) |
Sep 17, 2026 5w ago | 8-K | $0.9680 $0.6240 | ▼ −35.54% | ▼ −35.74% | $0.5110 (−47.21%) |
Sep 16, 2026 5w ago | DEFA14A | $0.8950 $0.6350 | ▼ −29.05% | ▼ −30.51% | $0.5110 (−42.91%) |
Sep 16, 2026 5w ago | 8-K | $0.8950 $0.6350 | ▼ −29.05% | ▼ −30.51% | $0.5110 (−42.91%) |
Sep 11, 2026 6w ago | Press Release | $0.8117 $0.7601 | ▲ +6.36% | ▲ +8.23% | $0.5110 (+37.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers